These novel therapies , Retatrutide, represent a groundbreaking advancement in managing metabolic dysfunction and possibly related ailments . These drugs are grouped as GLP-1 pathway activators , indicating these substances to emulate the endogenous GLP-1 hormone , stimulating metabolic productio